Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
160
-
Total 13F shares, excl. options
-
50,733,997
-
Shares change
-
+5,578,008
-
Total reported value, excl. options
-
$295,822,953
-
Value change
-
+$31,944,283
-
Put/Call ratio
-
96%
-
Number of buys
-
79
-
Number of sells
-
-59
-
Price
-
$5.83
Significant Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q3 2020
213 filings reported holding CLVSQ - CLOVIS ONCOLOGY INC - COM as of Q3 2020.
CLOVIS ONCOLOGY INC - COM (CLVSQ) has 160 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50,733,997 shares
.
Largest 10 shareholders include STATE STREET CORP (9,646,730 shares), VANGUARD GROUP INC (6,182,479 shares), BlackRock Inc. (5,956,075 shares), Palo Alto Investors LP (4,469,411 shares), MORGAN STANLEY (2,281,257 shares), ARMISTICE CAPITAL, LLC (1,848,000 shares), CITADEL ADVISORS LLC (1,524,516 shares), Candriam Luxembourg S.C.A. (1,385,558 shares), GEODE CAPITAL MANAGEMENT, LLC (1,331,618 shares), and NATIXIS (1,089,436 shares).
This table shows the top 160 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.